Acuta Capital Partners’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-46,200
| Closed | -$1.66M | – | 43 |
|
|
2024
Q3 | $1.66M | Sell |
46,200
-166,300
| -78% | -$5.97M | 1.34% | 23 |
|
|
2024
Q2 | $7.5M | Buy |
212,500
+28,000
| +15% | +$988K | 6.32% | 4 |
|
|
2024
Q1 | $5.24M | Buy |
184,500
+36,664
| +25% | +$1.04M | 3.4% | 11 |
|
|
2023
Q4 | $1.97M | Buy |
147,836
+1,336
| +0.9% | +$17.8K | 1.11% | 25 |
|
|
2023
Q3 | $1.31M | Buy |
146,500
+73,500
| +101% | +$659K | 0.88% | 28 |
|
|
2023
Q2 | $821K | Buy |
+73,000
| New | +$821K | 0.56% | 31 |
|